3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
3
Sarcoma
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Psychiatric Rehabilitation
4
sargramostim
2
Early Intervention, Educational
2
Drug Therapy
2
neratinib
1
ixabepilone
1
carboxyamido-triazole
1
Topotecan
1
Thiotepa
1
Thalidomide
1
Temozolomide
1
Surveys and Questionnaires
1
Specimen Handling
1
Rituximab
1
Respiratory Function Tests
1
Radiotherapy
1
Quality of Life
1
Positron-Emission Tomography
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxycodone
1
O(6)-benzylguanine
1
Nivolumab
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Morphine
1
Molecular Diagnostic Techniques
1
Methotrexate
1
Methadone
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Immunotherapy
×
Other hematologic neoplasm
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled